ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of life"

  • Abstract Number: PP05 • ACR Convergence 2024

    Reunion with Forgotten Relationships and Memories

    Noriko Okochi1, Eiji Oishi2, Kaoru Mitsuyama3, Emi Sorimachi3, Shiho Bando4, Yuka Hirama5, Nobuyuki Yajima6 and Masaaki Mori7, 1Rheumatic Disease and Vasculitis Support Network Japan, Tokyo, Japan, 2Rheumatic Disease and Vasculitis Support Network Japan, Yamaguchi, Japan, 3Institute of Neuropsychiatry, Tokyo, Tokyo, Japan, 4Ota-ku Children and Families Support Center, Ota-ku, Tokyo, Japan, 5Asada Ladies Clinic, Shinagawa, Japan, Tokyo, Japan, 6Showa-Universtiy of Medicine, Tokyo, Japan, 7Tokyo Medical and Dental University, Tokyo, Japan

    Background/Purpose: Paediatric rheumatic diseases are complex experiences for children.  For children whose language skills are still undeveloped, it is difficult for them to put their…
  • Abstract Number: 0614 • ACR Convergence 2024

    Bridging the Gap Between Patient’s Perception on Quality of Life and Disease Activity and Damage in Systemic Lupus Erythematous Patient

    Background/Purpose: Improving quality of life (QoL) is one of the key targets when treating systemic lupus erythematosus (SLE) patients. The Lupus impact Tracker (LIT) is…
  • Abstract Number: 1232 • ACR Convergence 2024

    Patient Reported Impact of Psoriatic Arthritis and Desired Treatment Outcomes

    Elizabeth Luce1, Beth schneider2 and Dianna cronin2, 1MyHealthTeam, San Francisco, CA, 2MyHealthTeams, San Francisco, CA

    Background/Purpose: People living with psoriatic arthritis often struggle with the physical and mental health toll. Understanding the holistic impact of psoriatic arthritis is crucial to…
  • Abstract Number: 2149 • ACR Convergence 2024

    Rheumatoid Arthritis: Patient’s Voice First! An Original Approach Based on Infodemiology Using Social Media Content – Results from the PRIMA Study

    Jérémie Sellam1, Luisa Attali2, Sonia Trope3, Paméla Voillot4 and Cécile Gaujoux-Viala5, 1Saint-Antoine Hospital - AP-HP, Paris, Ile-de-France, France, 2Centre de recherches en médecine, psychanalyse et société - Université Paris, Strasbourg, France, 3ANDAR, Paris, Ile-de-France, France, 4Kap code, Paris, France, 5CHU Nîmes, Nïmes, Languedoc-Roussillon, France

    Background/Purpose: Social media and online forums are popular for understanding patients' feelings and concerns, which are hard to assess with traditional methods. Infodemiology collects and…
  • Abstract Number: PP13 • ACR Convergence 2024

    Bridging the Gap from Pediatric to Adult Rheumatology Care

    Natasha Trehan, University of Ottawa, Take a Pain Check Foundation, Markham, ON, Canada

    Background/Purpose: When I was 13, life took an unexpected turn with a diagnosis of Juvenile Idiopathic Arthritis (JIA). Overnight, my world transformed into a cycle…
  • Abstract Number: 0616 • ACR Convergence 2024

    Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus

    Victoria Delk1, Dulaney Wilson2, Gary Gilkeson2, Jim Oates2 and Diane Kamen2, 1Medical University of South Carolina, North Charleston, SC, 2Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with the potential to severely diminish patients' quality of life (QoL). SLE disproportionately affects young…
  • Abstract Number: 1253 • ACR Convergence 2024

    Patterns of Patient-reported Outcome Measures in Patients with Systemic Lupus Erythematosus with or Without Concurrent Fibromyalgia

    Heather Gold1, Yi Li1, Rebecca Anthopolos1, Peter Izmirly2, Jill Buyon1, Mala Masson3, Brooke Cohen1, Kamil Barbour4, Amit Saxena5, H Michael Belmont5, Chung-E Tseng6 and Kelly Corbitt7, 1NYU Grossman School of Medicine, New York, NY, 2New York University Grossman School of Medicine, New York, NY, 3NYU Langone Medical Center- Division of Rheumatology, New York, NY, 4CDC, Alpharetta, GA, 5NYU School of Medicine, New York, NY, 6NYU Langone Health, Flushing, NY, 7University of Miami Miller School of Medicine, El Portal, FL

    Background/Purpose: Patients with SLE often have concomitant FM or symptoms similar to FM, including chronic pain, fatigue, sleep disturbance, and/or depression, potentially distinct from immune-mediated…
  • Abstract Number: 2150 • ACR Convergence 2024

    Understanding Unmet Needs and Quality of Life Impact of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) Using Social Media: A Patient and Caregiver Perspective

    Pallavi Arun1, Nikita Parashar1, Sakshi Sharma1, Kanika Arora1, Vandana Padmanabhan1 and Alvaro Arjona2, 1Novartis Healthcare Private Limited, Hyderabad, Telangana, India, 2Novartis Farmaceutica, S.A., Madrid, Madrid, Spain

    Background/Purpose: Analyzing social media conversations of patients (pts) and caregivers can be useful to understand the real-world perspectives thereby improving quality of healthcare.1 GCA and…
  • Abstract Number: PP16 • ACR Convergence 2024

    Utilization of My Knee Notes for Enhanced Healthcare Management

    Tien Sydnor-Campbell, Medically Retired, Philadelphia, PA

    Background/Purpose: Living with chronic knee issues for 40 years has been incredibly challenging. My knee pain began as early as 6th grade but got overlooked…
  • Abstract Number: 0626 • ACR Convergence 2024

    Impact of the Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) Patient Reported Outcome (PRO) in Systemic Lupus Erythematosus Patients from the Almenara Lupus Cohort

    Manuel Ugarte-Gil1, RV, Gamboa-Cardenas2, Victor Pimentel-Quiroz3, Cristina Reategui4, Claudia Elera Fitzcarrald5, Samira García-Hirsh6, José Alfaro-Lozano6, Cesar Pastor-Asurza6, Zoila Rodriguez-Bellido6, Risto Perich-Campos6 and Graciela Alarcon7, 1Universidad Cientifica del Sur, Lima, Lima, Peru, 2Universidad Científica del Sur, Lima, Lima, Peru, 3Universidad Científica del Sur/Hospital Nacional Guillermo Almenara Irigoyen, Magdalena del Mar, Peru, 4Servicio de Reumatología. Hospital Nacional Guillermo Almenara Irigoyen, EsSalud/Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Lima, Peru, 5Hospital Nacional Guillermo Almenara Irigoyen/Universidad San Ignacio de Loyola, Lima, Peru, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Lima, Peru, 7The University of Alabama at Birmingham, Oakland, CA

    Background/Purpose: Physician-reported disease activity has a modest association with patient-reported outcomes (PROs) in systemic lupus erythematosus patients. The aim of this study is to evaluate…
  • Abstract Number: 1254 • ACR Convergence 2024

    The Impact of Eosinophilic Granulomatosis with Polyangiitis on the Health-Related Quality of Life of Patients and Their Ability to Work: Evidence from a Real-World Survey in Clinical Practice

    Robert Spiera1, Paul Dolin2, Anat Shavit2, Jennifer Rowell3, Chris Edmonds4, Josefine Persson5, Danuta Kielar6, Daniel Mascia7, James Siddall7, Tia Pennant7, Fritha Hennessy7 and Stephanie Y. Chen8, 1Scleroderma, Vasculitis, and Myositis Center, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 2BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom, 3Market Access and Pricing, AstraZeneca, Cambridge, England, United Kingdom, 4Market Access and Pricing, AstraZeneca, Gaithersburg, MD, 5Market Access and Pricing, AstraZeneca, Gothenburg, Sweden, 6Biopharmaceuticals Medicine, AstraZeneca, Cambridge, United Kingdom, 7Adelphi Real World, Bollington, United Kingdom, 8BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

    Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody-associated vasculitis that confers significant disease burden. This real-world study described the impact of…
  • Abstract Number: 2152 • ACR Convergence 2024

    Factors Associated with Health-related Quality of Life in Adults with SAPHO and Chronic Nonbacterial Osteomyelitis – a Cross Sectional Analysis from the SAPHO-CNO Study

    Aleksander Lenert1, Helena Abodeely1, Karmela Kim Chan2, Sandy Hong3, Arundathi Jayatilleke4, Courtney Kremer5, Emma Leisinger1, Petar Lenert6, Melissa Oliver7, T. Shawn Sato8, Melanie Smith2, Thomason Jenna9, Yongdong (Dan) Zhao10, Jonathan Templin1, Robyn Domsic11, Mary Vaughan-Sarrazin1, Daniel Solomon12 and Polly Ferguson13, 1University of Iowa, Iowa City, IA, 2Hospital For Special Surgery, New York, NY, 3University of Iowa Stead Family Children's Hospital, Iowa City, IA, 4Temple University, Philadelphia, PA, 5University of Iowa Stead Family Children's Hospital, Solon, Iowa, IA, 6University of Iowa Hospitals and Clinics, Iowa City, IA, 7Indiana University, Indianapolis, IN, 8University of Iowa, Iowa City, 9University of Washington, Division of Rheumatology, Seattle, WA, 10University of Washington, Redmond, WA, 11Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 12Brigham and Women's Hospital, Newton, MA, 13University of Iowa Carver College of Medicine, Iowa City, IA

    Background/Purpose: Health-related quality of life (HRQOL) is decreased in individuals with chronic rheumatic diseases (CRD) yet remains undefined in adults with SAPHO syndrome and chronic…
  • Abstract Number: 0145 • ACR Convergence 2024

    Community Mobility in a Diverse Cohort of Individuals with Systemic Lupus Erythematosus

    Leila Milanfar1, Jinoos Yazdany2, Amanda Eudy3, Courtney Hoge4, Charmayne M. Dunlop-Thomas5, Patti Katz6 and Laura Plantinga7, 1University of California San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Duke University, Raleigh, NC, 4Emory University, Atlanta, GA, 5Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 6UCSF, San Rafael, CA, 7University of California, San Francisco, San Francisco, CA

    Background/Purpose: Measurement of the extent to which individuals move throughout their community and participate in social activities (“community mobility”) can provide a snapshot of how…
  • Abstract Number: 0635 • ACR Convergence 2024

    Medical Record Natural Language Processing and Patient Biometric and Self-Reported Measures Inform an Artificial Intelligence Augmented Remote Care Management Strategy for Lupus Patients

    Gerald Lushington1, Bruce Wang2, Mohan Purushothaman3, Melissa Munroe4, Vijay R. Nadipelli5, Bernard Rubin2, Jessica Crawley2, Beth Valashinas6, Reshma Khan7, Anil Warrier8, Joseph Huffstutter9, Jennifer Murphy10, Lizeth Santamaria2, Sneha Nair2, Georg Armstrong2, Sandeep Nair2, Daniele DeFreese3, Adrian Holloway3, Arif Sorathia2, Brett Adelman2, Fabricio Pautasso2 and Eldon Jupe3, 1Progentec Diagnostics, Inc, Oklahoma City, OK, 2Progentec Diagnostics, Inc., Oklahoma City, OK, 3Progentec Diagnostics, Inc., Oklahoma City, 4Oklahoma Medical Research Foundation; Progentec Diagnostics, Inc., Oklahoma City, OK, 5GSK, Medical Evidence Generation, Philadelphia, PA, 6Physicians Alliance of Connecticut, Milford, CT, 7Palm Beach Rheumatology and Wellness Center, Jupiter, FL, 8Millennium Rheumatology, Conroe, TX, 9Arthritis Associates PLLC, Signal Mountain, TN, 10Articularis Healthcare, Summerville, SC

    Background/Purpose: Systemic lupus erythematosus (SLE) is one of several rheumatologic disorders that presents frequent healthcare challenges, particularly for socioeconomic and geographically disadvantaged patients. Due to…
  • Abstract Number: 1319 • ACR Convergence 2024

    Impact of Illness Cognition and Self-Esteem on Quality of Life in Reproductive-Age Women with Autoimmune Rheumatic Diseases

    Ana Rodriguez-Flores1, Galilea Rodriguez2, Mara Ponce3, Anahí Carrazco Chapa4, Karen Aglae Chavez-Olivo2, Aldo Patricio Romero-Avila2, Valeria Monserrat De Hoyos-Perez5, Jesus Cardenas-de la Garza3, Lorena Perez-Barbosa6, CASSANDRA SKINNER TAYLOR7 and Dionicio Galarza-Delgado8, 1Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Mexico, 3Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, UANL, Rheumatology, Monterrey, Mexico, Monterrey, Mexico, 5Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 6Hospital Universitario, UANL, Monterrey, Mexico, 7HOSPITAL UNIVERSITARIO DR JOSE ELEUTERIO GONZALEZ, MONTERREY, Mexico, 8UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Autoimmune rheumatic diseases (ARDs) are inflammatory conditions associated with impaired joint mobility, recurrent pain, and fatigue leading to poor emotional health and negative feelings…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 30
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology